Real-time disaster intelligence, alerts, and response tools.
Wednesday, April 8, 2026
[ad_1] SHANGHAI, Sept. 21, 2024 /PRNewswire/ — During HUAWEI CONNECT 2024, Leon Wang, President of Huawei’s Data Communication Product Line, announced more than 20 all-new Xinghe Intelligent Network offerings globally at the summit themed “Xinghe Intelligent […]
[ad_1] – HANSIZHUANG ® (serplulimab) was the first anti-PD-1 monoclonal antibody (mAb) approved for first-line treatment of ES-SCLC – HETRONIFLY® (serplulimab) is expected to become the first anti-PD-1 monoclonal antibody available in Europe for first-line […]
[ad_1] Henlius e Intas reciben la opinión positiva del CHMP para HETRONIFLY® (aprobado como HANSIZHUANG en China) en los mercados europeos como tratamiento de primera línea para pacientes adultos con cáncer de pulmón de células pequeñas […]
[ad_1] HANSIZHUANG (serplulimab) is the world’s first anti-PD-1 mAb for first-line treatment of ES- SCLC – HANSIZHUANG (serplulimab) is expected to become the first and only anti-PD-1 monoclonal antibody available in Europe for first-line treatment of […]
[ad_1] NEW DELHI, Sept. 21, 2024 /PRNewswire/ — Translumina was incorporated in 2011 as a sales & marketing company specialising in coronary intervention devices. Since its inception, the company has successfully established their own manufacturing […]
